First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.49 USD 6.9% Market Closed
Updated: Mar 29, 2024

ADC Therapeutics SA
Operating Expenses

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ADC Therapeutics SA
Operating Expenses Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
Operating Expenses
$-233m
CAGR 3-Years
-2%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Operating Expenses
CHf-68.4m
CAGR 3-Years
4%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Operating Expenses
$-593.7m
CAGR 3-Years
-19%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Operating Expenses
CHf-111.6m
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
-4%
Idorsia Ltd
SIX:IDIA
Operating Expenses
CHf-893.8m
CAGR 3-Years
-21%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Operating Expenses
CHf-28.5m
CAGR 3-Years
-27%
CAGR 5-Years
-13%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's Operating Expenses?
Operating Expenses
-233m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Operating Expenses amounts to -233m USD.

What is ADC Therapeutics SA's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-13%

Over the last year, the Operating Expenses growth was 29%. The average annual Operating Expenses growth rates for ADC Therapeutics SA have been -2% over the past three years , -13% over the past five years .